Closure of a muscular ventricular septal defect using the Amplatzer ventricular occluder

Majid Dehghani1, Mohammad-Bagher Sharifkazemi, Amir Aslani

  • 1Catheterization and Cardiovascular Intervention Unit, Shaheed Lavasani Hospital, Tehran, Iran.

Insights

Transcatheter closure using the Amplatzer device offers a safe and effective alternative to surgical repair for ventricular septal defects. This minimally invasive technique demonstrates high success rates and fewer complications for patients.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Pediatric Cardiology

Background:

  • Surgical closure of ventricular septal defects (VSDs) carries risks including cardiopulmonary bypass complications and potential heart block.
  • Minimally invasive transcatheter occlusion is increasingly preferred over surgical repair for VSD closure.
  • The Amplatzer muscular VSD occluder represents an advanced device for transcatheter VSD treatment.

Observation:

  • An 18-year-old patient presented with a ventricular septal defect.
  • The patient underwent transcatheter closure of the VSD.
  • The Amplatzer muscular VSD occluder was utilized for the procedure.

Findings:

  • Transcatheter closure of the VSD was successfully performed using the Amplatzer occluder.
  • The Amplatzer device demonstrated safety and a high success rate in this patient.
  • This represents the first reported use of the Amplatzer VSD occluder in Iran.

Implications:

  • Transcatheter VSD closure with the Amplatzer device is a viable and effective treatment option.
  • This technique may reduce the risks associated with traditional surgical VSD repair.
  • Expanding the use of the Amplatzer occluder can improve VSD management in Iran and beyond.

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...